A synthetic lethal screen identifies ATR-inhibition as a novel therapeutic approach for POLD1-deficient cancers

The phosphoinositide 3-kinase-related kinase ATR represents a central checkpoint regulator and mediator of DNA-repair. Its inhibition selectively eliminates certain subsets of cancer cells in various tumor types, but the underlying genetic determinants remain enigmatic. Here, we applied a synthetic...

Descripción completa

Detalles Bibliográficos
Autores principales: Hocke, Sandra, Guo, Yang, Job, Albert, Orth, Michael, Ziesch, Andreas, Lauber, Kirsten, De Toni, Enrico N, Gress, Thomas M., Herbst, Andreas, Göke, Burkhard, Gallmeier, Eike
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872770/
https://www.ncbi.nlm.nih.gov/pubmed/26755646
http://dx.doi.org/10.18632/oncotarget.6857

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872770/
https://www.ncbi.nlm.nih.gov/pubmed/26755646
http://dx.doi.org/10.18632/oncotarget.6857

Ejemplares similares